Director/PDMR Shareholding

RNS Number : 5105C
Advanced Medical Solutions Grp PLC
13 April 2017


13 April 2017

            Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)


            Director/PDMR and PCA Shareholding


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that it was notified on 11 April 2017 that Jeff Willis, who is a Senior Manager and PDMR, had sold 100,000 Ordinary Shares of 5p on 10 April 2017.


The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them



Details of the person discharging managerial responsibilities/person closely associated


Name: Jeff Willis


Reason for the notification


Position/status: PDMR


Initial notification/Amendment: Initial Notification


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor


Name:   Advanced Medical Solutions Group plc




Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594


Nature of the transactions:

·        Sale of 100,000 Ordinary Shares of 5p




Price(s) and volume(s):

Sale of shares:






Aggregated information: (Relates to those shares sold only)

Aggregated volume: 100,000

Aggregated price: £2.6025


Date of the transaction: 10/04/2017


Place of the transaction: London Stock Exchange, AIM Market (XLON)



End –



For further information, please visit or contact:


Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Chief Financial Officer

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys

Investec Bank plc (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb


About Advanced Medical Solutions Group plc see

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal®, and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand® and RESORBA®.

AMS’s products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 600 employees.  For more information, please see

This information is provided by RNS
The company news service from the London Stock Exchange